Literature DB >> 30583056

Diagnostic tools for immune causes of encephalitis.

A M Lascano1, M I Vargas2, P H Lalive3.   

Abstract

BACKGROUND: Autoimmune encephalitis (AE) refers to a central nervous system (CNS) antibody-mediated entity characterized by a rapid onset behavioural and cognitive decline that can be associated with movement disorders, epileptic and dysautonomic features. Interestingly, it is thought to be as common as its infectious disease counterpart and can share some clinical, radiological, and laboratory findings.
OBJECTIVES: The aim is to describe the main clinical features of AE caused by antibodies targeting cell-surface neuronal agents and the diagnostic means to identify them. Paraneoplastic syndromes, associated with intracellular antibodies, will not be tackled in this review. SOURCES: PubMed/MEDLINE were the sources. CONTENT: According to a recent population-based study, autoimmunity is one of the most frequent cause of encephalitis after infectious agents. Its diagnosis lies upon 'classic' clinical features, which are dominated by neuropsychiatric symptoms and epileptic seizures. Cerebral spinal fluid (CSF) and serum autoantibody testing can confirm AE. Complementary examination with magnetic resonance imaging (MRI) and electroencephalogram (EEG) may be helpful for excluding other causes and managing seizures. In addition, exclusion of infectious and other origins must be considered. IMPLICATIONS: AE misdiagnosis can lead to a delay in treatment onset and, thus, clinical worsening. In this sense, identifying the causative agent is of utmost importance. However, the absence of CSF or serum antibody detection does not exclude the diagnosis of AE. Despite extensive testing, many encephalitis cases remain of unknown origin. It is obvious that some autoantibodies have not yet been identified in AE. Since radiological and biological examinations are not always contributive, early symptom recognition might help to hasten the diagnostic process.
Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoantibody; Cerebrospinal fluid; Limbic; Magnetic resonance imaging; Seizure

Mesh:

Substances:

Year:  2018        PMID: 30583056     DOI: 10.1016/j.cmi.2018.12.012

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis.

Authors:  V Fominykh; L Brylev; V Gaskin; R Luzin; A Yakovlev; I Komoltsev; I Belousova; A Rosliakova; A Guekht; N Gulyaeva
Journal:  Metab Brain Dis       Date:  2019-07-02       Impact factor: 3.584

2.  Optimal encephalitis/meningitis roadmap via precise diagnosis and treatment (IMPROVE): a study protocol for a randomized controlled trial.

Authors:  Yi Zhang; Haocheng Zhang; Bo Deng; Ke Lin; Lei Jin; Xiaoni Liu; Yanlin Zhang; Xiaohua Chen; Yanliang Zhang; Shengjia Lu; Heqing Huang; Qiujing Wang; Tingting Feng; Weifeng Zhao; Qun Xue; Renfang Chen; Jingbo Zhang; Xiaoyan Qian; Lanlan Chen; Jingwen Ai; Xiangjun Chen; Wenhong Zhang
Journal:  BMC Infect Dis       Date:  2022-01-08       Impact factor: 3.090

Review 3.  Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review.

Authors:  Shuyu Zhang; Chengyuan Mao; Xinwei Li; Wang Miao; Junfang Teng
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.